ID29027A - Turunan-turunan heteroaromatik yang mempunyai aktivitas penghambatan terhadap integrase hiv - Google Patents

Turunan-turunan heteroaromatik yang mempunyai aktivitas penghambatan terhadap integrase hiv

Info

Publication number
ID29027A
ID29027A IDW00200101355A ID20011355A ID29027A ID 29027 A ID29027 A ID 29027A ID W00200101355 A IDW00200101355 A ID W00200101355A ID 20011355 A ID20011355 A ID 20011355A ID 29027 A ID29027 A ID 29027A
Authority
ID
Indonesia
Prior art keywords
heteroaromatic
damages
hazard
against hiv
activities against
Prior art date
Application number
IDW00200101355A
Other languages
English (en)
Indonesian (id)
Inventor
Toshio Fujishita
Tomokazu Yoshinaga
Akihito Sato
Original Assignee
Shionogi & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shionogi & Co filed Critical Shionogi & Co
Publication of ID29027A publication Critical patent/ID29027A/id

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4196—1,2,4-Triazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/24—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/30—Hetero atoms other than halogen
    • C07D333/34—Sulfur atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
IDW00200101355A 1998-12-25 1999-12-17 Turunan-turunan heteroaromatik yang mempunyai aktivitas penghambatan terhadap integrase hiv ID29027A (id)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP37127098 1998-12-25
JP24747999 1999-09-01

Publications (1)

Publication Number Publication Date
ID29027A true ID29027A (id) 2001-07-26

Family

ID=26538287

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW00200101355A ID29027A (id) 1998-12-25 1999-12-17 Turunan-turunan heteroaromatik yang mempunyai aktivitas penghambatan terhadap integrase hiv

Country Status (22)

Country Link
US (3) US6620841B1 (fr)
EP (1) EP1142872B1 (fr)
JP (1) JP3929244B2 (fr)
KR (1) KR20010089708A (fr)
CN (1) CN1178913C (fr)
AP (1) AP2001002169A0 (fr)
AT (1) ATE411286T1 (fr)
AU (1) AU763040B2 (fr)
BR (1) BR9916583A (fr)
CA (1) CA2353961A1 (fr)
CZ (1) CZ20012160A3 (fr)
DE (1) DE69939749D1 (fr)
HK (1) HK1042701A1 (fr)
HU (1) HUP0201472A3 (fr)
ID (1) ID29027A (fr)
IL (1) IL143958A0 (fr)
NO (1) NO20013179L (fr)
NZ (1) NZ512184A (fr)
PL (1) PL348596A1 (fr)
RU (1) RU2225860C2 (fr)
TR (1) TR200101886T2 (fr)
WO (1) WO2000039086A1 (fr)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6380249B1 (en) 1998-06-03 2002-04-30 Merck & Co., Inc. HIV integrase inhibitors
US6306891B1 (en) 1998-06-03 2001-10-23 Merck & Co., Inc. HIV integrase inhibitors
US6262055B1 (en) 1998-06-03 2001-07-17 Merck & Co., Inc. HIV integrase inhibitors
DE69925918T2 (de) 1998-07-27 2006-05-11 Istituto Di Ricerche Di Biologia Molecolare P. Angeletti S.P.A. Diketosäure-derivate als hemmstoffe von polymerasen
GB9816358D0 (en) 1998-07-27 1998-09-23 Angeletti P Ist Richerche Bio Enzyme inhibitors
CN1367784A (zh) * 1999-06-02 2002-09-04 盐野义制药株式会社 新的取代丙烯酮衍生物的制备方法
EP1196384A4 (fr) * 1999-06-25 2002-10-23 Merck & Co Inc 1,3-propanediones-1-(aromatiques ou heteroaromatiques substitutees)-3-(heteroaromatiques substituees) et leur utilisation
CA2410763A1 (fr) * 2000-06-13 2002-11-28 Shionogi & Co., Ltd. Compositions medicinales contenant des derives de propenone
AU2001262732A1 (en) * 2000-06-14 2001-12-24 Shionogi And Co., Ltd. Inhibitor for enzyme having two divalent metal ions as active centers
AU2002212701A1 (en) * 2000-11-09 2002-05-21 Shionogi And Co., Ltd. Drug-tolerant hiv integrases
KR20100087209A (ko) 2001-08-10 2010-08-03 시오노기세이야쿠가부시키가이샤 항바이러스제
RS51542B (sr) * 2001-10-26 2011-06-30 Istituto Di Ricerche Di Biologia Molecolare P.Angeletti Spa. N-supstituisani hidroksipirimidinon karboksamidni inhibitori hiv integraze
TW200407132A (en) * 2001-11-15 2004-05-16 Shionogi & Co Process for producing 1-H-1,2,4-triazole-3-carboxylic acid ester
JP4497347B2 (ja) * 2001-12-05 2010-07-07 塩野義製薬株式会社 Ｈｉｖインテグラーゼ阻害活性を有する誘導体
WO2004024693A1 (fr) 2002-08-13 2004-03-25 Shionogi & Co., Ltd. Compose heterocyclique a activite inhibitrice de l'integrase du vih
WO2004035577A2 (fr) 2002-10-16 2004-04-29 Gilead Sciences, Inc. Composes tricycliques pre-organises inhibiteurs d'integrase
CN1569803B (zh) * 2003-07-16 2011-04-13 中国科学院上海药物研究所 芳基β－二酮酸的新制备方法
AU2005208938A1 (en) * 2004-01-29 2005-08-11 Elixir Pharmaceuticals, Inc Anti-viral therapeutics
IN2014CN03762A (fr) * 2004-08-25 2015-09-25 Ardea Biosciences Inc
EP1790638B1 (fr) * 2004-09-15 2013-04-03 Shionogi Co., Ltd. Dérivé de carbamoylpyridone ayant une activité d'inhibition de la vih intégrase
EP1819323B2 (fr) * 2004-12-03 2023-03-22 Merck Sharp & Dohme Corp. Composition pharmaceutique renfermant un agent d'anti-nucleation
UA87884C2 (uk) * 2004-12-03 2009-08-25 Мерк Энд Ко., Инк. Безводна кристалічна калієва сіль інгібітора віл-інтегрази
US7250421B2 (en) * 2005-01-31 2007-07-31 University Of Georgia Research Foundation, Inc. Diketo acids with nucleobase scaffolds: anti-HIV replication inhibitors targeted at HIV integrase
US20080280849A1 (en) * 2005-06-01 2008-11-13 Herve Leh Synergic Combinations Comprising a Quinoline Compound and Other Hiv Infection Therapeutic Agents
WO2007136714A2 (fr) * 2006-05-16 2007-11-29 Gilead Sciences, Inc. Inhibiteurs d'intégrase
EP2046328A4 (fr) * 2006-07-19 2009-10-28 Univ Georgia Res Found Dicétoacides de pyridinone : inhibiteurs de la réplication du vih dans une thérapie combinée
WO2008041882A1 (fr) * 2006-10-03 2008-04-10 Viktor Veniaminovich Tets Procédé pour agir sur les virus au moyen d'une substance à base de 2,8-dithioxo-1h- pyrano[2,3-d;6,5-d'] dipyrimidine et de leurs analogues 10-aza (et variantes)
CN102670628B (zh) 2008-01-25 2015-11-25 奇默里克斯公司 治疗病毒感染的方法
US8664255B2 (en) 2008-10-20 2014-03-04 The Texas A&M University System Inhibitors of mycobacterium tuberculosis malate synthase, methods of making and uses thereof
AU2010328325B2 (en) 2009-12-07 2015-02-05 University Of Georgia Research Foundation, Inc. Pyridinone hydroxycyclopentyl carboxamides: HIV integrase inhibitors with therapeutic applications
DK2534150T3 (en) 2010-02-12 2017-06-12 Chimerix Inc METHODS OF TREATING VIRUS INFECTION
EP2550362B1 (fr) 2010-03-25 2017-01-04 Oregon Health&Science University Glycoprotéines du cmv et vecteurs recombinés
CN101928258B (zh) * 2010-08-18 2014-10-29 杭州民生药业有限公司 1-(2-取代苯胺基-4-甲基-噻唑-5)-3-取代苯基-丙烯酮衍生物、制备方法及其制药用途
PT2691530T (pt) 2011-06-10 2018-05-10 Univ Oregon Health & Science Glicoproteínas e vectores recombinantes cmv
WO2014026033A1 (fr) * 2012-08-08 2014-02-13 University Of Florida Research Foundation, Inc. Epitopes de lymphocytes t à réactivité croisée du vih, du vis et du vif pour des vaccins destinés à des humains et à des chats
MD4736C1 (ro) 2012-12-21 2021-07-31 Gilead Sciences, Inc. Compus policiclic de carbamoilpiridonă şi utilizarea farmaceutică a acestuia
HUE037347T2 (hu) 2013-07-12 2018-08-28 Gilead Sciences Inc Policiklusos karmaboilpiridon vegyületek és alkalmazásuk HIV fertõzések kezelésére
NO2865735T3 (fr) 2013-07-12 2018-07-21
TWI677489B (zh) 2014-06-20 2019-11-21 美商基利科學股份有限公司 多環型胺甲醯基吡啶酮化合物之合成
NO2717902T3 (fr) 2014-06-20 2018-06-23
TW201613936A (en) 2014-06-20 2016-04-16 Gilead Sciences Inc Crystalline forms of(2R,5S,13aR)-8-hydroxy-7,9-dioxo-n-(2,4,6-trifluorobenzyl)-2,3,4,5,7,9,13,13a-octahydro-2,5-methanopyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazepine-10-carboxamide
TWI695003B (zh) 2014-12-23 2020-06-01 美商基利科學股份有限公司 多環胺甲醯基吡啶酮化合物及其醫藥用途
PL3277691T3 (pl) 2015-04-02 2019-07-31 Gilead Sciences, Inc. Policykliczne związki karbamoilopirydonowe i ich zastosowanie farmaceutyczne
CN106905244B (zh) * 2017-02-27 2019-08-16 武汉工程大学 二芳基嘧啶-二酮酸类杂合型hiv-1抑制剂及其制备方法
BR112022008074A2 (pt) * 2019-10-28 2022-07-12 Shanghai Inst Materia Medica Cas Composto de ácido oxocarboxílico heterocíclico de cinco membros e uso médico do mesmo
CN111943899B (zh) * 2020-09-08 2023-04-21 河北凯诺中星科技有限公司 一种5-甲酸乙酯四氮唑的合成方法
CN113683574B (zh) * 2021-09-06 2023-11-17 上海晋鲁医药科技有限公司 一种合成1-甲基-1h-1,2,4-三唑-3-甲酸甲酯的方法

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3899508A (en) 1974-04-12 1975-08-12 Lilly Co Eli 5-(2-Aminophenyl)pyrazole-3-carboxylic acids and esters thereof
US3931247A (en) 1974-12-11 1976-01-06 Morton-Norwich Products, Inc. 5-(Substituted)phenylfurfuryl alcohols
JPS5811878B2 (ja) 1974-12-19 1983-03-04 大正製薬株式会社 フロ （ ３ ２−ｂ ） インド−ルルイノ セイホウ
JPS56100784A (en) 1980-01-16 1981-08-12 Yoshitomi Pharmaceut Ind Ltd Indolizine derivative
US4273776A (en) 1980-01-30 1981-06-16 E. R. Squibb & Sons, Inc. Antibacterial and antifungal derivatives of 3-(1H-imidazol-1-yl)-2-propen-1-ones
US4423063A (en) 1980-12-29 1983-12-27 Merck & Co., Inc. 2,4-Dioxo-4-substituted-1-butaoic acid derivatives useful in treating urinary track calcium oxalate lithiasis
US4336397A (en) 1980-12-29 1982-06-22 Merck & Co., Inc. 2,4-Dioxo-4-substituted-1-butanoic acid derivatives useful in treating urinary tract calcium oxalate lithiasis
US4332735A (en) 1981-07-06 1982-06-01 Morton-Norwich Products, Inc. Antifungal compound
US4637829A (en) 1984-04-27 1987-01-20 Ciba-Geigy Corporation Sulfonylureas
JPS61134346A (ja) 1984-12-03 1986-06-21 Shionogi & Co Ltd ４−オキソカルボン酸誘導体および抗潰瘍剤
CA1334975C (fr) * 1987-11-13 1995-03-28 James H. Holms Composes inhibiteurs de type lipoxygenase contenant des groupes furane et pyrrole
JPH0238403A (ja) 1988-07-28 1990-02-07 Canon Inc 光重合性組成物および記録媒体
PH27357A (en) 1989-09-22 1993-06-21 Fujisawa Pharmaceutical Co Pyrazole derivatives and pharmaceutical compositions comprising the same
US5192773A (en) * 1990-07-02 1993-03-09 Vertex Pharmaceuticals, Inc. Immunosuppressive compounds
TW224974B (fr) * 1991-07-02 1994-06-11 Hoffmann La Roche
EP0658559A1 (fr) * 1993-12-14 1995-06-21 Chemisch Pharmazeutische Forschungsgesellschaft m.b.H. Dérivés thiénothianine, procédé pour leur préparation et leur application comme inhibiteurs de 5-dipoxygenase et cyclooxygenase
US5475109A (en) 1994-10-17 1995-12-12 Merck & Co., Inc. Dioxobutanoic acid derivatives as inhibitors of influenza endonuclease
US5693804A (en) * 1994-11-17 1997-12-02 Molecular Geriatrics Corporation Substituted 1-aryl-3-piperazin-1'-yl propanones
NZ337698A (en) 1997-04-04 2001-07-27 Pfizer Prod Inc Nicotinamide derivatives for selective inhibition of phosphodiesterase type 4 (PDE4) and the production of tumour necrosis factor (TNF) useful for the treatment of respiratory, rheumatoid and allergic diseases
IL122591A0 (en) 1997-12-14 1998-06-15 Arad Dorit Pharmaceutical compositions comprising cystein protease inhibitors
CN1142909C (zh) 1998-03-26 2004-03-24 盐野义制药株式会社 具有抗病毒活性的吲哚衍生物
AU3366899A (en) 1998-03-27 1999-10-18 Regents Of The University Of California, The Novel hiv integrase inhibitors and hiv therapy based on drug combinations including integrase inhibitors
JP2002516858A (ja) 1998-06-03 2002-06-11 メルク エンド カムパニー インコーポレーテッド Ｈｉｖインテグラーゼ阻害薬
AU757409B2 (en) 1998-06-03 2003-02-20 Merck & Co., Inc. Hiv integrase inhibitors
EP1082121A4 (fr) * 1998-06-03 2003-02-05 Merck & Co Inc Inhibiteurs de vih integrase
EP1196384A4 (fr) 1999-06-25 2002-10-23 Merck & Co Inc 1,3-propanediones-1-(aromatiques ou heteroaromatiques substitutees)-3-(heteroaromatiques substituees) et leur utilisation

Also Published As

Publication number Publication date
RU2225860C2 (ru) 2004-03-20
HUP0201472A2 (hu) 2003-10-28
CN1335834A (zh) 2002-02-13
BR9916583A (pt) 2001-09-25
RU2001120016A (ru) 2003-12-10
AU763040B2 (en) 2003-07-10
WO2000039086A1 (fr) 2000-07-06
US6645956B1 (en) 2003-11-11
EP1142872A1 (fr) 2001-10-10
CN1178913C (zh) 2004-12-08
DE69939749D1 (de) 2008-11-27
EP1142872B1 (fr) 2008-10-15
US7098201B2 (en) 2006-08-29
ATE411286T1 (de) 2008-10-15
EP1142872A4 (fr) 2002-04-17
US6620841B1 (en) 2003-09-16
HK1042701A1 (zh) 2002-08-23
NO20013179D0 (no) 2001-06-22
US20040002485A1 (en) 2004-01-01
HUP0201472A3 (en) 2006-03-28
AP2001002169A0 (en) 2001-06-30
NO20013179L (no) 2001-08-27
CA2353961A1 (fr) 2000-07-06
JP3929244B2 (ja) 2007-06-13
NZ512184A (en) 2003-08-29
IL143958A0 (en) 2002-04-21
TR200101886T2 (tr) 2001-12-21
CZ20012160A3 (cs) 2001-10-17
PL348596A1 (en) 2002-06-03
AU1797900A (en) 2000-07-31
KR20010089708A (ko) 2001-10-08

Similar Documents

Publication Publication Date Title
ID29027A (id) Turunan-turunan heteroaromatik yang mempunyai aktivitas penghambatan terhadap integrase hiv
ID28376A (id) Pirimidina yang menghambat replikasi hiv
IS6164A (is) Málmpróteasa latar
DE10197409A5 (de) Verringerung der gegenseitigen Störung von drahtlosen Systemen
MX240911B (es) Combinaciones de herbicidas y protectores.
DE60224568D1 (de) Nach dem hot-melt-verfahren arbeitende tinten
PL370664A1 (en) Hiv integrase inhibitors
ITMI20001308A0 (it) Apparecchio di taglio.
ID27975A (id) Peralatan penjepit gulungan
ID25688A (id) Peralatan peredam ganda
ID27207A (id) Turunan-turunan piridin yang menghambat pde iv
IT1314012B1 (it) Apparecchiatura per la finitura di superfici metalliche.
PT1164877E (pt) Equipamento de pulverizacao
PL359366A1 (en) Substituted heteroaryloxyacetanilides and their use as herbicides
ES1041767Y (es) Perfil metalico para estructuras y similares.
ES1042893Y (es) Dispositivo para prevencion de caidas.
DE59908689D1 (de) Walzwerk
GB9814930D0 (en) HIV integrase inhibitors
ITPC990020A0 (it) Attrezzatura per la fabbricazione di fiocchi - coccarde per uso decora tivo.
DK1043026T3 (da) Melanombehandling
FI4060U1 (fi) Kelaustyökalu
DE29906956U1 (de) Transportable Werkstätte
ES1039321Y (es) Tripode para formacion de mesas y similares.
ITSP990009U4 (it) Congegno di sollevo/sollievo lungodegenti.
AU2002321973A1 (en) Arylpiperazines and arylpiperidines and their use as metalloproteinase inhibiting agents